Aferian PLC Swings to Profit with 36% Revenue Surge in H1 2025
Aferian's H1 turnaround: $1.7m profit & 36% revenue jump, though refinancing due Sept 2025 creates material uncertainty.
This article covers information on Aferian PLC.
LON:AFRNA Turnaround Worth Streaming: Aferian’s Profit Surprise
Well, colour me intrigued. Aferian’s H1 2025 results aren’t just an improvement – they’re a full-throttle pivot. That 36% revenue surge to $16.6m and swing from a $2.4m adjusted EBITDA loss to a $1.7m profit? That’s the kind of momentum investors dream about. CEO Mark Carlisle isn’t wrong when he talks about building on H2 2024’s foundations. But – and there’s always a ‘but’ – let’s peel back the layers beyond the headline fireworks.
Financial Highlights: More Than Just Top-Line Sparkle
Beyond the impressive revenue jump, several metrics signal genuine operational progress:
- Cash Flow Breathing Room: Adjusted operating cash flow swung dramatically to a $1.1m inflow (from a painful $5.0m outflow in H1 2024). That’s oxygen for a business that’s been gasping.
- Inventory Discipline: Stock levels slashed to $2.1m (down from $4.0m a year ago). Less cash tied up in warehouses means more flexibility.
- Recurring Revenue Stability: Exit run-rate ARR crept up 2% to $14.4m. Not explosive, but crucially, 24i stemmed the churn bleeding seen previously.
Where the Growth Engine Fired: Amino Takes the Lead
The real star of this show? Amino. Its 94% revenue explosion to $9.3m wasn’t just luck. Stronger sales execution translated into:
- Significant order boosts from existing Pay TV clients.
- Successful deployments of next-gen Enterprise Video & Digital Signage (EVDS) solutions.
- Their SaaS device management platform proving sticky and driving recurring income.
This wasn’t just selling more widgets; it was validating their strategy in the EVDS space – a key future growth vector.
24i: Holding the Fort & Building Foundations
While Amino sprinted, 24i held firm at $7.4m revenue. Flat year-on-year might seem underwhelming, but context is key:
- This figure absorbs the full impact of losing two major customers back in FY23. Stabilisation after that hit is a win.
- New wins (like launching the Revry LGBTQ+ network) offset churn, keeping ARR stable.
- Product innovation (AI personalisation, advanced ad tools) is strengthening the pipeline. The focus is shifting from firefighting to building.
The Elephant in the Boardroom: That Refinancing
Let’s not sugar-coat it. The impressive H1 numbers dance against a stark backdrop:
- Net Debt: Stood at $14.6m at period-end (up from $12.7m Nov 2024, but comparable to $14.4m adjusted Nov 2024).
- The Sword of Damocles: Existing bank facilities mature end of September 2025. Renegotiations are ongoing, but the RNS is crystal clear: “…as no agreements have yet been signed there remains uncertainty that a refinancing will be successfully completed.”
- Going Concern Caveat: The accounts are prepared on a going concern basis, but the directors explicitly state a “material uncertainty exists” due to the refinancing risk. That $1.3m shareholder loan due Jan 2026 adds another layer.
Cash flow and covenant headroom are being tightly managed, but this isn’t just a footnote – it’s the critical plot twist for H2. The operational turnaround is undeniable, but the balance sheet needs fixing. Pronto.
Outlook: Conditional Confidence
Assuming the refinancing gets over the line, the outlook has genuine pep:
- A “strong H2 2025 order book” cited, particularly for Amino devices.
- Full-year revenue now expected to be ~20% ahead of FY24.
- FY25 results overall anticipated to be “in line with the Board’s expectations“.
Carlisle’s confidence in converting the pipeline and scaling software revenue sounds credible – if the funding foundation is secured.
The Takeaway: Progress Painted in Bold Strokes, But the Canvas Needs Securing
Aferian’s H1 is a textbook example of operational execution starting to deliver. Amino’s resurgence is impressive, 24i’s stabilisation is reassuring, and the cash flow swing is vital. The company feels like it’s found its strategic footing in the B2B streaming space.
However, the investment case boils down to a binary near-term event: successful refinancing. The operational momentum and H2 visibility make a compelling case for lenders, but until the ink is dry on new facilities, the risk premium remains elevated.
This is a turnaround showing real muscle. Now, it needs to secure its financial footing to let that muscle flex properly. Watch the RNS wires closely in the coming weeks – the next announcement might be the most important one yet.
Related
Keep reading
Investing
AstraZeneca’s Enhertu delivers Phase III lung cancer PFS win
Enhertu delayed disease progression versus standard care in a Phase III lung cancer trial, supporting its potential move into first-line treatment.
JoshuaAugust 17, 2026
Investing
Optima Health FY26 results: growth beats expectations as PAM integration begins
Optima Health beat adjusted EBITDA expectations in FY26, while the £100 million PAM acquisition reshaped its growth prospects and balance sheet.
JoshuaAugust 17, 2026
Investing
Nostrum Oil & Gas Agrees $304.6 Million Kazakhstan Sale Ahead of Wind-Down
Nostrum plans to sell its Kazakhstan operations, repay secured notes in full and begin an orderly wind-down after completion.
JoshuaAugust 17, 2026
Last updated
Category
InvestingLikes
Star Rating
No ratings yet
Comments
No comments yet - start the conversation.